PDS Biotechnology Corpora... (PDSB)
NASDAQ: PDSB
· Real-Time Price · USD
1.20
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
1.22
1.66%
After-hours: Aug 15, 2025, 07:12 PM EDT
PDS Biotechnology Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.49M | -7.95M | -10.73M | -8.33M | -10.6M | -10.9M | -10.85M | -11.54M | -9.66M | -19.14M | -7.42M | -5.82M | -8.47M | -6.32M | -6.96M | -589K | -3.05M |
Depreciation & Amortization | 5.46K | 15.13K | 15.13K | 15.13K | 4.74K | 4.74K | 4.73K | 4.74K | 3.15K | 11.57K | 97.67K | 86.00 | 86.00 | 951.00 | 1.27K | 1.27K | 1.86K |
Stock-Based Compensation | 1.25M | 1.64M | 1.78M | 1.8M | 1.63M | 1.35M | 2.07M | 2.11M | 2.08M | 1.37M | 1.34M | 1.35M | 1.13M | 1.67M | 1.7M | 441.6K | 293.37K |
Other Working Capital | -3.46M | -2.62M | 2.58M | -143.29K | -267.37K | -1.22M | 92K | 1.82M | -6.66M | 5.87M | -142.6K | -640.8K | -521.11K | 220.06K | 998.74K | -392.74K | -644.43K |
Other Non-Cash Items | 485.54K | 297.87K | 305.43K | 550.87K | 279.26K | 447.98K | 550.27K | -957.55K | 193.21K | 4.24M | 170.4K | 60.17K | 60.26K | 60.26K | 60.26K | 60.26K | 60.26K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 232.59K | n/a | 1.41M | n/a | n/a | -97.67K | n/a | n/a | -10.6M | n/a | n/a | n/a |
Change in Working Capital | -2.29M | -2.24M | 628.44K | -2.89M | -1.25M | 400.69K | 1.04M | 4.16M | -5.8M | 5.05M | 16.8K | -1.51M | 915.2K | 83.88K | 68.97K | 1.03M | -1.11M |
Operating Cash Flow | -9.03M | -8.23M | -8M | -8.86M | -9.94M | -8.46M | -7.18M | -4.81M | -13.19M | -7.53M | -5.89M | -5.92M | -6.37M | -4.5M | -5.13M | 946.23K | -3.8M |
Capital Expenditures | n/a | n/a | n/a | -29K | n/a | -4 | n/a | 4.00 | -4 | 3.00 | -4 | -2 | -1 | 5.00 | 5.00 | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -28.97M | n/a | -29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | -3.14M | -3.14M | -14.11K | -13.79K | -13.47K | -13.17K | -12.88K | -12.59K | -20.67K | n/a | 25M | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.16M | 143.78K | 98.5K | n/a | 531.48K | 300.17K | n/a | 8.85K | 4.59M | -149.46K | -449.33K | n/a | n/a | n/a | n/a | 220.6K | n/a |
Financial Cash Flow | 7.32M | 172.78K | 17.22K | -13.79K | 20.01M | 10.77M | 802.33K | 240.01K | 4.57M | 9.71M | 24.55M | 22.43K | 7.49K | 13.00 | 123.51K | 48.77M | n/a |
Net Cash Flow | -1.71M | -8.06M | -7.98M | -8.9M | 10.07M | 2.31M | -6.37M | -4.57M | -8.62M | 2.18M | 18.66M | -5.9M | -6.36M | -4.5M | -5M | 49.71M | -3.8M |
Free Cash Flow | -9.03M | -8.23M | -8M | -8.89M | -9.94M | -8.46M | -7.18M | -4.81M | -13.19M | -7.53M | -5.89M | -5.92M | -6.37M | -4.5M | -5.13M | 946.23K | -3.8M |